A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants

NCT03169725 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1417

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Inactivated Poliomyelitis Vaccine (Sabin strain)
BIOLOGICAL: Inactivated Poliomyelitis Vaccine (Salk strain)

Sponsor

LG Chem